Buy BPC-157 + TB-500 in Canada
BPC-157 + TB-500 comes as one freeze-dried vial holding both repair peptides at a fixed 1:1 split: 5 mg of each in the 10 mg size and 10 mg of each in the 20 mg size. Vistara Labs stocks the BPC-157 + TB-500 blend in both sizes, and this guide covers what is in the vial, what the research on the pair has found and how to buy BPC-157 TB-500 Canada-wide.
View product →At a glance: Vistara Labs stocks BPC-157 + TB-500 in 10 mg (5 + 5) and 20 mg (10 + 10) vials and as a ready-mixed nasal spray, independently tested at 99.6% purity, with a certificate of analysis on our Lab Reports page, shipped from within Canada by Canada Post Xpresspost, with same-business-day dispatch on orders before 3 pm Pacific, Monday to Friday. We deliver to every province, including Ontario, Quebec, British Columbia and Alberta.
What is in a BPC-157 + TB-500 vial?
The pairing is sold as the Wolverine blend, the Wolverine stack or the Healing Blend. No name fixes the contents, so the milligrams of each peptide are the figure worth comparing:
| Vial size | BPC-157 | TB-500 |
|---|---|---|
| 10 mg | 5 mg | 5 mg |
| 20 mg | 10 mg | 10 mg |
The 10 mg vial is not 10 mg of BPC-157 with some TB-500 added; it is half of each. Where a protocol is written around 10 mg of BPC-157, the 20 mg vial is the matching size. Our article on the Wolverine stack traces where the nickname came from.
Why are BPC-157 and TB-500 paired?
BPC-157 is a 15-amino-acid peptide drawn from a protective protein in gastric juice. Its laboratory literature centres on blood-vessel formation, tendon and ligament models and the gut lining.
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4, an actin-binding protein released by platelets and many other cells after tissue injury. Its research centres on cell migration and new blood-vessel growth.
They come at repair from different directions rather than duplicating each other, which is why they are combined in one vial.
What has research on BPC-157 and TB-500 found?
- Knee pain, 2021. A Florida clinic reviewed a year of charts for patients who had received BPC-157 directly into the knee, alone or with thymosin beta-4. Of the 16 patients reached by phone, 14 (87.5%) reported relief of their knee pain: 11 of 12 on BPC-157 alone and 3 of 4 on the combination. It is the closest published record of the two used together.
- Venous leg ulcers, 2010. A double-blind, placebo-controlled Phase 2 trial at eight European sites randomised 73 patients to topical thymosin beta-4 or placebo. The safety profile at every strength tested was comparable to placebo, and the authors reported that the 0.03% strength may speed wound closure, with complete closure within three months in about a quarter of patients.
Product specifications from vistaralabs.ca, October 2026. Research background: Lee E, Padgett B. Altern Ther Health Med. 2021. PMID 34324435. Guarnera G, DeRosa A, Camerini R. Ann N Y Acad Sci. 2010. PMID 20536470.
Blend, separate vials or the nasal spray?
- Both peptides in one vial: the BPC-157 + TB-500 blend, in 10 mg or 20 mg.
- A different ratio, or one peptide alone: separate BPC-157 and TB-500 vials. Blend or separate vials? works through that choice.
- No reconstitution at all: the BPC-157 + TB-500 Nasal Spray, 10 mg of each in 10 mL of sterile saline, ready-mixed in a sealed metered atomiser.
What comes with a BPC-157 + TB-500 order?
- A published certificate. The blend’s certificate of analysis reports 99.6% purity; the single BPC-157 and TB-500 vials report 99.8% and 99.6%.
- Bacteriostatic water. The BPC-157 reconstitution guide and the peptide calculator cover the arithmetic.
- Domestic shipping. Orders ship from within Canada by Canada Post Xpresspost, the same business day when placed before 3 pm Pacific, Monday to Friday, so there is no customs step.
BPC-157 + TB-500 is supplied for laboratory research use only. For background, see BPC-157 and TB-500 for knee pain, TB-500 and thymosin beta-4 and our guide to buying BPC-157 in Canada.
Frequently asked questions
Why is BPC-157 + TB-500 called the Wolverine blend?
It is a comic-book nickname, after the character known for rapid recovery, that spread through online forums. The same pairing is also sold as the Healing Blend. Neither name sets a standard, so the milligrams of each peptide are what to compare.
How much of each peptide is in the 10 mg vial?
5 mg of BPC-157 and 5 mg of TB-500. The 20 mg vial holds 10 mg of each.
What has research on BPC-157 and TB-500 together shown?
In a 2021 review of 16 knee-pain patients, 14 reported relief after BPC-157 given into the knee, including 3 of the 4 who received it with thymosin beta-4, the protein TB-500 is based on.
Is there a BPC-157 + TB-500 nasal spray?
Yes. The BPC-157 + TB-500 Nasal Spray holds 10 mg of each peptide in 10 mL of sterile saline, about 57 sprays at 350 mcg per spray, and arrives ready-mixed.
Where can I buy BPC 157 TB 500 in Canada?
Vistara Labs stocks the blend in 10 mg and 20 mg vials and as a nasal spray, shipped from within Canada by Canada Post Xpresspost to every province.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.
References
No controlled human trial of the BPC-157 + TB-500 combination was identified. In the retrospective knee-pain review below, four patients received BPC-157 with full-length thymosin β4 — a different molecule from TB-500.
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainRetrospective chart review, 17 patients (16 followed up by telephone); no control group, no blinding, no validated outcome instrument.
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potentialAnalytical chemistry: characterises TB-500 as the N-terminally acetylated 17-23 fragment of thymosin β4 (Ac-LKKTETQ), not the intact 43-amino-acid protein.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewSystematic review; 544 records screened, 36 studies included — 35 preclinical and 1 clinical.
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.
